This year, the UW Department of Global Health (DGH) welcomes 65 new graduate students. These newest Huskies hail from 15 different countries (Afghanistan, Canada, China, Colombia, Indonesia, Kenya, Malawi, Mozambique, Nigeria, Peru, Rwanda, Sudan, Tunisia, Uganda, United States). They join the 139 continuing students already enrolled in Global Health MPH and PhD programs (68 MPH students, 45 PhD in Global health students, and 26 PhD in Pathobiology students).
The University of Washington Tuberculosis Research & Training Center (TRTC) held its fourth annual Tuberculosis Symposium on September 16, 2019. Over 100 researchers from UW, Seattle Children’s Research Institute, Stanford University, IHME, and others participated in the symposium. The Symposium, entitled “Innovations to help end the TB epidemic; a new vision for the 21st century,” featured sessions on TB vaccines, the risk of TB disease in children, and TB control interventions, and showcased innovations to help end the TB epidemic, both locally and globally.
Around this time last year, news outlets blared alarming headlines: Breathing the air outside was as bad as smoking several cigarettes. Wildfire haze blotted out the sun and turned the moon orange. Weather apps simply listed the forecast as “smoke.”
Just because this summer has been clear, though, doesn’t mean that the environment is doing just fine.
The Global Health Immersion Program (GHIP) is the University of Washington’s flagship global health program for preclinical medical students. Since 2003, the program has sent students to developing countries to deepen their understanding of healthcare delivery abroad, the causes of illness, and the impacts on communities.
The University of Washington’s School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy. This interdisciplinary project will explore ways in which community pharmacists can better support people living with this neurological disorder.
The roughly 3.4 million people nationally and 75,000 people in Washington state who live with epilepsy often get fragmented and uncoordinated healthcare and community services.
Globally, 25 percent of new HIV cases occur among young women and adolescent girls in Africa. Pre-exposure prophylaxis, or PrEP, prevents infection when taken consistently, but stigma around the disease keeps some young women from maintaining usage, according to a new review by researchers at the University of Washington.
Sometimes you have to spend money to save money — and a major new report finds that spending $1.8 trillion on climate adaptation projects would result in $7.1 trillion in total net benefits. The report predicts that the most impressive returns will come from investments that strengthen early warning systems for disasters like storms and floods.
As part of the Ending the HIV Epidemic (EHE): A Plan for America initiative, the University of Washington/Fred Hutch Center for AIDS Research (CFAR) received $1.2 million to fund five research projects. This initiative allocates funding to HIV research with the goal of reducing new infections in the United States by 90 percent by 2030.
From Myanmar and Mozambique to the US and Egypt, 90 participants from 22 countries around the world traveled to Seattle August 26-30 for the University of Washington Department of Global Health intensive summer course in The Fundamentals of Implementation Science in Global Health. The one-week course taught participants systematic approaches that can be used to bring research findings to on-the-ground settings, with the ultimate aim of improving health for people around the world.
Dr. Kenneth Mugwanya is an Assistant Professor and core faculty member in the Department of Global Health. His research interests aim to develop, evaluate, and implement interventions likely to have the greatest impact to prevent new HIV infections. Recently, Mugwanya and several co-authors conducted a study investigating the feasibility of providing antiretroviral drugs at family clinics. The study took place in Kenya, where Mugwanya is a director of two large PrEP studies.